Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 19, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research
08:06

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Published on: May 21, 2008

8.7K

Editorial

Colin B Begg1

  • 1Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Clinical Trials (London, England)
|September 13, 2019
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Last Updated: Jan 19, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research
08:06

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Published on: May 21, 2008

8.7K

Related Concept Videos

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research08:06

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

8.7K
In the past many in vitro culture systems -- mainly monolayer cultures -- often suffered from the disadvantage that differentiated primary cells had a relatively short life-span and de-differentiated during culture. As a consequence, most of their organ-specific functions were lost rapidly. Thus, in order to reproduce better conditions for these cells in vitro, modifications and adaptations have been made to conventional monolayer...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Association of Inherited Genetic Variants with Multiple Primary Melanoma.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025
Same author

Sex differences in melanoma survival-a GEM study.

JNCI cancer spectrum·2025
Same author

Identifying somatic fingerprints of cancers defined by germline and environmental risk factors.

Genetic epidemiology·2024
Same author

Topical hidden genome: discovering latent cancer mutational topics using a Bayesian multilevel context-learning approach.

Biometrics·2024
Same author

Predicting Cancer Risk from Germline Whole-exome Sequencing Data Using a Novel Context-based Variant Aggregation Approach.

Cancer research communications·2023
Same journal

A statistical evaluation of decision-making methods and the efficiency of Bayesian multi-arm multi-stage trials.

Clinical trials (London, England)·2026
Same journal

Accounting for non-adherence: A re-analysis of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results trial.

Clinical trials (London, England)·2026
Same journal

Phase I design for partially ordered groups with late-onset toxicity.

Clinical trials (London, England)·2026
Same journal

Trial informed consent forms, the Declaration of Helsinki and the SPIRIT 2025 statement.

Clinical trials (London, England)·2026
Same journal

17th Annual University of Pennsylvania Conference on statistical issues in clinical trials - Covariate adjustment in randomized clinical trials: New methods and applications (Morning panel discussion).

Clinical trials (London, England)·2026
Same journal

17th Annual University of Pennsylvania Conference on statistical issues in clinical trials - Covariate adjustment in randomized clinical trials: New methods and applications (Afternoon panel discussion).

Clinical trials (London, England)·2026
See all related articles